EGX-358

N/A

Report date: 2025/01/26 17:13:43
NME

Base Information

Drug NameEGX-358
Drug Alias NameEstrogen Receptor Beta Agonist (University of Wisconsin-Milwaukee/Marquette University/Estrigenix Therapeutics)EGX-358
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEstrogen receptor beta agonists
TargetsEstrogen receptor beta
Therapy Area/IndicationsMenopausal symptomsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Wisconsin, Milwaukee
China Registration ClassN/A

Develop Information

Active CompaniesMarquette UniversityUniversity Of Wisconsin, MilwaukeeEstrigenix Therapeutics
Inactive CompaniesN/A
Active IndicationsMenopausal symptomsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A